DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,049,016 | -62.8% | 444,498 | -0.7% | 0.00% | -100.0% |
Q2 2023 | $2,818,721 | +62.5% | 447,416 | +48.8% | 0.00% | – |
Q1 2023 | $1,734,601 | -38.4% | 300,624 | +9.5% | 0.00% | -100.0% |
Q4 2022 | $2,816,073 | -83.0% | 274,471 | -72.4% | 0.00% | -75.0% |
Q3 2022 | $16,614,000 | +1201.0% | 993,645 | +989.1% | 0.00% | – |
Q2 2022 | $1,277,000 | -32.5% | 91,237 | -22.1% | 0.00% | – |
Q1 2022 | $1,892,000 | +30.3% | 117,132 | +72.7% | 0.00% | – |
Q4 2021 | $1,452,000 | +79.3% | 67,838 | +23.0% | 0.00% | – |
Q3 2021 | $810,000 | +93.3% | 55,134 | +161.6% | 0.00% | – |
Q2 2021 | $419,000 | -83.2% | 21,078 | -74.7% | 0.00% | -100.0% |
Q1 2021 | $2,495,000 | – | 83,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $66,961,644 | 24.44% |
Cormorant Asset Management, LP | 5,150,000 | $52,839 | 3.54% |
Logos Global Management LP | 2,797,501 | $28,702,360 | 3.36% |
RA Capital Management | 2,971,231 | $30,484,830 | 0.62% |
Ghost Tree Capital, LLC | 82,853 | $850,000 | 0.36% |
Avoro Capital Advisors LLC | 2,272,222 | $23,312,998 | 0.35% |
EcoR1 Capital, LLC | 884,903 | $9,079,105 | 0.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 57,025 | $585,077 | 0.17% |
Ikarian Capital, LLC | 48,500 | $497,610 | 0.12% |
Rock Springs Capital Management LP | 460,391 | $4,723,612 | 0.11% |